Search

for
Search:

GlossaryInfliximab (Remicade)

blocks TNF-alpha to reduce inflammation in autoimmune diseases

Infliximab, also known by the brand name Remicade, is a medication that works by blocking a protein called tumor necrosis factor-alpha (TNF-alpha). This protein is involved in inflammatory processes in the body. By inhibiting TNF-alpha, infliximab helps reduce inflammation and is used to treat autoimmune conditions such as rheumatoid arthritis, Crohn's disease, and psoriasis.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 30 results

research North American Clinical Management Guidelines for Hidradenitis Suppurativa: A Publication from the United States and Canadian Hidradenitis Suppurativa Foundations

256 citations, March 2019 in “Journal of the American Academy of Dermatology”

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

research Safety of Dermatologic Medications in Pregnancy and Lactation

159 citations, March 2014 in “Journal of The American Academy of Dermatology”

Some skin medications are safe during pregnancy and breastfeeding, but others can harm the baby and should be avoided.

research Psoriasis Treatment in Difficult Locations: Scalp, Nails, and Intertriginous Areas

104 citations, August 2008 in “Clinics in Dermatology”

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

research Safety of Dermatologic Medications in Pregnancy and Lactation

73 citations, March 2014 in “Journal of The American Academy of Dermatology”

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

research Drugs and Hair Loss: Mechanisms and Clinical Implications

54 citations, September 2012 in “Dermatologic Clinics”

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

View more "remicade" in research →

Community Join

0 / 0 results

— no results